SCHEMBL20095505

SCHEMBL20095505

CN[C@@H]1CCN(c2cccc(C(F)(F)F)c2)C[C@H]1N(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.52
▸ SCN9A Q15858 2/20 0.49
▸ ALDH1A1 P00352 4/20 0.46
▸ CASR P41180 3/20 0.46
▸ HTR3E A5X5Y0 1/20 0.45
▸ HTR3B O95264 1/20 0.45
▸ HTR1D P28221 1/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ HTR3A P46098 1/20 0.45
▸ HTR3D Q70Z44 1/20 0.45
▸ HTR3C Q8WXA8 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ THRB P10828 1/20 0.44
▸ ACACB O00763 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ ALOX12 P18054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20063477 0.88 SCN9A (0.50) NOTUMSCN9AALDH1A1CASRHTR3E
SCHEMBL21904711 0.87 CASR (0.51) NOTUMSCN9AALDH1A1CASRHTR3E
SCHEMBL20063498 0.87 CASR (0.51) NOTUMSCN9AALDH1A1CASRHTR3E
SCHEMBL20063904 0.83 NOTUM (0.57) NOTUMSCN9AALDH1A1CASRHTR3E
SCHEMBL20063903 0.81 NOTUM (0.51) NOTUMSCN9ACASRMAPTTHRB
SCHEMBL11544167 0.81 NOTUM (0.57) NOTUMALDH1A1CASRHTR3EHTR3B
SCHEMBL20095504 0.78 NOTUM (0.49) NOTUMSCN9AALDH1A1CASRHTR3E
SCHEMBL21838591 0.78 NOTUM (0.57) NOTUMSCN9AALDH1A1MAPTACACB
SCHEMBL17754046 0.78 ALDH1A1 (0.59) NOTUMALDH1A1HTR3EHTR3BHTR1D
SCHEMBL20096221 0.76 NOTUM (0.54) NOTUMALDH1A1CASRHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018072602-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2018-04-26 — — WO disclosed
Send feedback